The liver is among the most vital organs in the body, and receiving a liver cancer diagnosis can be frightening and confusing. October is National Liver Cancer Awareness Month, a time for patients, their loved ones and advocates to bring attention to the disease.
Many patients with liver cancer typically don’t show symptoms until the disease is beyond the primary stage and the cancer has advanced and spread to other parts of the body. When this occurs, tumors in secondary sites are known as metastatic liver cancer. The most common site for liver metastasis is the lungs.
Reno CyberKnife treats patients with metastatic liver cancer with a procedure called stereotactic body radiation therapy using CyberKnife® technology. During the procedure, the robotic radiosurgery system delivers targeted, high dose radiation directly to tumors with extreme precision. Treatment is noninvasive and is completed within five or fewer outpatient sessions.
For those with metastatic liver cancer in the lungs, CyberKnife has particular benefits. The CyberKnife’s virtually unlimited maneuverability and respiratory tracking technology compensates and corrects for normal patient movement such as breathing, allowing for a safe and accurate treatment of lesions in the lungs. This advantage can have a positive impact for eligible patients who are seeking an alternative treatment option to surgery with fewer side effects, while concurrently undergoing other forms of treatment.
For more information about liver cancer and support resources, visit the American Liver Foundation website.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.